Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Sebti

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Microcirculation (New York, N.Y. : 1994)|July 1, 1994
Desensitization of 5HT2 receptors by protein kinase C activation in distal pulmonary vascular smooth muscle cells in cultureW Weng, I J Reynolds, J P Jani, et al.
The Journal of Biological Chemistry|November 24, 1999
Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s)L Liu, P Moesner, N L Kovach, et al.
The Journal of Biological Chemistry|April 18, 1997
The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformationG J Clark, M S Kinch, K Rogers-Graham, et al.
Archives of Biochemistry and Biophysics|February 10, 2000
TGF-beta1 stimulation of fibronectin transcription in cultured human lung fibroblasts requires active geranylgeranyl transferase I, phosphatidylcholine-specific phospholipase C, protein kinase C-delta, and p38, but not erk1/erk2U Kucich, J C Rosenbloom, G Shen, et al.
Oncogene|December 15, 2000
Inhibition of farnesyltransferase increases TGFbeta type II receptor expression and enhances the responsiveness of human cancer cells to TGFbetaJ Adnane, F A Bizouarn, Z Chen, et al.
Molecular and Cellular Biology|December 14, 1999
The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosisK Jiang, D Coppola, N C Crespo, et al.
Archives of Biochemistry and Biophysics|October 25, 2001
Signaling events required for transforming growth factor-beta stimulation of connective tissue growth factor expression by cultured human lung fibroblastsU Kucich, J C Rosenbloom, D J Herrick, et al.
The Journal of Biological Chemistry|April 29, 1994
Design and structural requirements of potent peptidomimetic inhibitors of p21ras farnesyltransferaseY Qian, M A Blaskovich, M Saleem, et al.
Cancer Research|October 16, 1999
Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabineJ Sun, M A Blaskovich, D Knowles, et al.
Cancer Research|April 15, 1996
The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblastsE J Bernhard, G Kao, A D Cox, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Microcirculation (New York, N.Y. : 1994)|July 1, 1994
Desensitization of 5HT2 receptors by protein kinase C activation in distal pulmonary vascular smooth muscle cells in cultureW Weng, I J Reynolds, J P Jani, et al.
The Journal of Biological Chemistry|November 24, 1999
Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s)L Liu, P Moesner, N L Kovach, et al.
The Journal of Biological Chemistry|April 18, 1997
The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformationG J Clark, M S Kinch, K Rogers-Graham, et al.
Archives of Biochemistry and Biophysics|February 10, 2000
TGF-beta1 stimulation of fibronectin transcription in cultured human lung fibroblasts requires active geranylgeranyl transferase I, phosphatidylcholine-specific phospholipase C, protein kinase C-delta, and p38, but not erk1/erk2U Kucich, J C Rosenbloom, G Shen, et al.
Oncogene|December 15, 2000
Inhibition of farnesyltransferase increases TGFbeta type II receptor expression and enhances the responsiveness of human cancer cells to TGFbetaJ Adnane, F A Bizouarn, Z Chen, et al.
Molecular and Cellular Biology|December 14, 1999
The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosisK Jiang, D Coppola, N C Crespo, et al.
Archives of Biochemistry and Biophysics|October 25, 2001
Signaling events required for transforming growth factor-beta stimulation of connective tissue growth factor expression by cultured human lung fibroblastsU Kucich, J C Rosenbloom, D J Herrick, et al.
The Journal of Biological Chemistry|April 29, 1994
Design and structural requirements of potent peptidomimetic inhibitors of p21ras farnesyltransferaseY Qian, M A Blaskovich, M Saleem, et al.
Cancer Research|October 16, 1999
Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabineJ Sun, M A Blaskovich, D Knowles, et al.
Cancer Research|April 15, 1996
The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblastsE J Bernhard, G Kao, A D Cox, et al.
Pageof 11